Citigroup
SPPI

Citigroup’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Citigroup’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-400
Closed -$3K – 7863
2019
Q2 		$3K Sell
400
-3,300
-89% -$29.5K ﹤0.01% 7585
2019
Q1 		$40K Sell
3,700
-8,400
-69% -$90K ﹤0.01% 6525
2018
Q4 		$106K Buy
12,100
+3,500
+41% +$44.6K ﹤0.01% 5612
2018
Q3 		$144K Sell
8,600
-7,100
-45% -$154K ﹤0.01% 5553
2018
Q2 		$329K Buy
15,700
+11,500
+274% +$213K ﹤0.01% 4530
2018
Q1 		$68K Buy
4,200
+2,900
+223% +$57.4K ﹤0.01% 5947
2017
Q4 		$25K Buy
+1,300
New +$23.5K ﹤0.01% 6628

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Citigroup's SPPI Position: Q4 2022 in Review

Citigroup sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 2,064 shares — an estimated $1K sold.

Citigroup first reported a position in SPPI in Q2 2013 and held it in 38 quarters. The position peaked at $4.39M in Q2 2018. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • Citigroup reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 2,064 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $1K.
  • Citigroup first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 38 quarters.
  • Citigroup's Spectrum Pharmaceuticals Inc position peaked at $4.39M in Q2 2018.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.